Market Tracker

11/21 6:05pm ET

Merck & Co Inc (NYSE:MRK)

59.66
Data as of Nov 21
 +0.28 / +0.47%
Today’s Change
47.61
Today|||52-Week Range
61.33
+19.20%
Year-to-Date
Get Your Wallet Out: Global Drug Spending is About to Hit a Dubious Milestone
10:19am / MotleyFool.com
Dow Jones (DJIA) Today: Merck (MRK) Leads The Day Higher, Caterpillar (CAT) Lags
Nov 17 / TheStreet.com
Today's Momo Momentum Stock Is Merck (MRK)
Nov 21 / TheStreet.com
Botox maker bought for $66 billion in biggest deal of 2014
Nov 17 / CNNMoney.com
Buy Gilead Sciences
Nov 21 / TheStreet.com
Pfizer Strikes Pact with Merck After Abandoning AstraZeneca
Nov 17 / TheStreet.com
Regeneron & Sanofi Present Positive Data on PCSK9 Drug - Analyst Blog
Nov 20 / Zacks.com
Merck Announces That IMPROVE-IT Achieved Primary Endpoint; Data To Be Presented At Am...
Nov 17 / Benzinga
Gilead Gains on Harvoni's EU Approval for HCV Treatment - Analyst Blog
Nov 19 / Zacks.com
Pandering Your Wealth Away
Nov 12 / MotleyFool.com
Pharma Industry Outlook: M&A, Licensing Abound - Zacks Analyst Interviews
Nov 19 / Zacks.com
Bill Ackman's Latest Target: Zoetis Inc.
Nov 12 / MotleyFool.com
Pharma Industry Outlook: M&A, Licensing Abound - Industry Outlook
Nov 19 / Zacks.com
This Tiny Biotech Is Piggybacking on Gilead Sciences, Inc.'s Success
Nov 12 / MotleyFool.com
3 Stocks Reiterated As A Buy: MRK, QCOM, V
Nov 18 / TheStreet.com
Gilead Sciences Inc. Breathes a Sigh of Relief -- Hepatitis C Patients, Not So Much
Nov 11 / MotleyFool.com
Merck IMPROVEs-IT Causing These Biotechs' Stock Prices to Improve Too
Nov 18 / MotleyFool.com
Merck Reports Interim Data on Hepatitis C Virus Drug - Analyst Blog
Nov 10 / Zacks.com
Merck Updates on Anti-PD-1 Drug Keytruda Phase II Study - Analyst Blog
Nov 17 / Zacks.com
Perrigo joins wave of OTC drug deals
Nov 06 / FT.com
Will Merck (MRK) Stock Be Helped Today by Zetia Study?
Nov 17 / TheStreet.com
AstraZeneca strikes deals on cancer drugs
Nov 04 / FT.com
3 Stocks Moving The Drugs Industry Upward
Nov 17 / TheStreet.com
US energy retreats on bearish Goldman call
Oct 27 / FT.com
Cramer: Pfizer Deal With Merck Leaves AstraZeneca In the Cold
Nov 17 / TheStreet.com
Stocks: 4 things to know before the open
Oct 27 / CNNMoney.com